James L. Tyree is President & VP at ABBOTT LABORATORIES (ABT). They have made 14 open-market trades across 4 companies since 2006, most recently 2026-06-16.
CIK 0001324991
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases since 2024, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GNLX | SELL | 2024-12-30 | 2024-12-30 | $2.46 | $9K | +1.7% | +70.0% | +12.5% |
| GNLX | SELL · 10b5-1 | 2024-09-11 | 2024-09-12 | $2.60 | $4K | -18.0% | -0.4% | -2.6% |
| ASRT | SELL | 2024-03-14 | 2024-03-15 | $1.12 | $11K | -10.8% | -26.6% | -6.3% |
| GNLX | SELL | 2023-12-13 | 2023-12-14 | $13.10 | $192K | -1.3% | -15.5% | -56.9% |
| ASRT | SELL · 10b5-1 | 2023-05-05 | 2023-05-05 | $6.00 | $259K | +14.7% | +0.0% | -13.7% |
| CCXI | SELL | 2022-08-04 | 2022-08-08 | $50.22 | $502K | +0.6% | +1.6% | -79.8% |
| CCXI | SELL | 2022-06-09 | 2022-06-13 | $25.65 | $197K | +12.1% | -1.3% | +120.8% |
| ASRT | SELL | 2022-05-12 | 2022-05-16 | $2.36 | $211K | +12.0% | +2.2% | +34.1% |
| CCXI | SELL | 2021-12-17 | 2021-12-21 | $34.86 | $2.0M | +5.5% | -24.1% | -30.8% |
| CCXI | SELL · 10b5-1 | 2021-05-21 | 2021-05-24 | $9.76 | $24K | +1.8% | +29.5% | +49.4% |
| CCXI | SELL | 2020-01-13 | 2020-01-15 | $37.06 | $2.2M | +8.3% | +26.3% | +28.1% |
| CCXI | SELL · 10b5-1 | 2016-05-23 | 2016-05-24 | $4.39 | $24K | +23.3% | +6.8% | +5.9% |
| INVA | SELL · 10b5-1 | 2016-05-18 | 2016-05-20 | $10.47 | $9K | +3.6% | +0.4% | +7.5% |
| THRX | SELL · 10b5-1 | 2015-06-02 | 2015-06-04 | $16.85 | $41K | -6.0% | -1.1% | -1.1% |
| CCXI | SELL · 10b5-1 | 2015-05-22 | 2015-05-26 | $7.45 | $95K | -48.7% | -9.1% | -9.1% |
| ABT | SELL · 10b5-1 | 2009-02-27 | 2009-03-03 | $47.68 | $498K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2009-02-17 | 2009-02-19 | $54.09 | $301K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2009-02-02 | 2009-02-18 | $55.26 | $1.9M | -8.3% | -2.3% | -2.3% |
| ABT | SELL | 2009-02-02 | 2009-02-04 | $54.74 | $3.0M | -8.3% | -2.3% | -2.3% |
| ABT | SELL | 2009-02-02 | 2009-02-04 | $54.75 | $4.1M | -8.3% | -2.3% | -2.3% |
| ABT | SELL | 2008-03-04 | 2008-03-06 | $53.04 | $535K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2008-03-03 | 2008-03-04 | $53.21 | $779K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2008-02-19 | 2008-02-20 | $56.08 | $50K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2007-06-01 | 2007-06-05 | $56.62 | $2.7M | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2007-02-15 | 2007-02-20 | $52.83 | $79K | -8.3% | -2.3% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.